DIANTHUS BIOPHARMA CONSULTING, LLC Trademark
Trademark Overview
On Wednesday, May 27, 2026, a trademark application was filed for DIANTHUS BIOPHARMA CONSULTING, LLC with the United States Patent and Trademark Office. The USPTO has given the DIANTHUS BIOPHARMA CONSULTING, LLC trademark a serial number of 99848286. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, May 27, 2026. This trademark is owned by Dianthus Biopharma Consulting, LLC. The DIANTHUS BIOPHARMA CONSULTING, LLC trademark is filed in the Computer & Software Services & Scientific Services, Personal and Legal & Social Services categories with the following description:
Technical consulting in the field of pharmaceutical studies; Product development consultation; Advisory services in the field of product development; Product development consulting in the field of pharmaceutical and biopharma product development and manufacture
Regulatory compliance consulting in the field of pharmaceuticals; Regulatory compliance consulting in the field of biotechnology; Regulatory compliance consulting in the field of chemistry, manufacturing and controls (CMC)
General Information
| Serial Number | 99848286 |
| Word Mark | DIANTHUS BIOPHARMA CONSULTING, LLC |
| Filing Date | Wednesday, May 27, 2026 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Wednesday, May 27, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Description of Mark | The mark consists of a hexagon containing a stylized flower with a DNA double helix in the center. To the right of the hexagon is the wording "DIANTHUS" in a stylized font, positioned above the wording "BIOPHARMA CONSULTING, LLC". |
| Goods and Services | Technical consulting in the field of pharmaceutical studies; Product development consultation; Advisory services in the field of product development; Product development consulting in the field of pharmaceutical and biopharma product development and manufacture |
| Pseudo Mark | DIANTHUS BIOPHARMA CONSULTING LLC |
| Goods and Services | Regulatory compliance consulting in the field of pharmaceuticals; Regulatory compliance consulting in the field of biotechnology; Regulatory compliance consulting in the field of chemistry, manufacturing and controls (CMC) |
| Pseudo Mark | DIANTHUS BIOLOGICAL PHARMACEUTICAL CONSULTING LIMITED LIABILITY COMPANY |
| Pseudo Mark | DIANTHUS BIOPHARMA CONSULTING LIMITED LIABILITY COMPANY |
| Pseudo Mark | DIANTHUS BIOLOGICAL PHARMACEUTICAL CONSULTING LLC |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 27, 2026 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 27, 2026 |
| Primary Code | 045 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Dianthus Biopharma Consulting, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Yardley, PA 19067
US |
Trademark Events
| Event Date | Event Description |
| Wednesday, May 27, 2026 | NEW APPLICATION ENTERED |
| Wednesday, May 27, 2026 | APPLICATION FILING RECEIPT MAILED |
